Loading insider details...
Beta
Latest Form 4 (Jun 11, 2025): Grant/Award of 30,000 INDP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2025 | Indaptus Therapeutics, Inc. (INDP) | Grant/Award | 30,000 | n/a |
| Apr 11, 2025 | Indaptus Therapeutics, Inc. (INDP) | Disposition to Issuer | 500 | $250.00 |
| Nov 27, 2024 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 9,034 | n/a |
| Sep 12, 2024 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 9,034 | n/a |
| Jun 24, 2024 | Viracta Therapeutics, Inc. (VIRX) | Grant/Award | 50,000 | n/a |
| Jun 7, 2024 | Indaptus Therapeutics, Inc. (INDP) | Grant/Award | 30,000 | n/a |
| May 29, 2024 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 9,035 | n/a |
| Feb 27, 2024 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 9,034 | n/a |
| Nov 28, 2023 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 9,034 | n/a |
| Aug 29, 2023 | Viracta Therapeutics, Inc. (VIRX) | Exercise/Conversion | 9,034 | n/a |